Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer-Reference-Cited by-同舟云学术

Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer

Published:2019-10 Issue:1 Volume:293 Page:49-57
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Kim Rihyeon¹^ORCID,Chang Jung Min¹^ORCID,Lee Han-Byoel¹,Lee Su Hyun¹^ORCID,Kim Soo-Yeon¹^ORCID,Kim Eun Sil¹^ORCID,Cho Nariya¹^ORCID,Moon Woo Kyung¹^ORCID

Affiliation:

1. From the Departments of Radiology (R.K., J.M.C., S.H.L., S.Y.K., E.S.K., N.C., W.K.M.) and Breast Surgery (H.B.L.), Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea; and Department of Healthcare Center, Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Republic of Korea (R.K.).

Funder

Seoul National University Hospital

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2019190014

Reference33 articles.

1. Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

2. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

3. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer